Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Ameriprise Financial Inc. - MarketBeat
18 hours ago • Google News
Syndax Pharmaceuticals Inc (SNDX)
US$ 13.330.23%
Price Chart
Key Statistics
Market Cap
$ 985.24M
P/E Ratio
0.00
Revenue (TTM)
$ 43.72M
Volume
716.52K
52W High
$ 25.07
52W Low
$ 8.58
Dividend Yield
0.00%
Beta
0.74
Technicals
50-Day MA
11.469
200-Day MA
15.1723
52 Week High
25.07
52 Week Low
8.58
About SNDX
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
Employees
270
Headquarters
New York, NY
CEO
Mr. Michael A. Metzger M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg